• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Santinelli’s unveils Xtrimer SE-1 industrial edging platform

Article

Santinelli International recently unveiled its Xtrimer SE-1 Industrial Edger featuring dry-cut lens edging technology.

Hauppauge, NY-Santinelli International recently unveiled its Xtrimer SE-1 Industrial Edger featuring dry-cut lens edging technology. The Xtrimer SE-1 has a “V” tool design, which introduces a new and efficient method of dry-cutting and milling, addressing the growing complexities of frame shapes and lens materials.

Incorporating 5 individual processing tools, the Xtrimer SE-1 expedites the roughing process on all organic lens materials, including Trivex and polycarbonate. The unit completes the 3-D cutting cycle and is capable of making tiltable bevel profiles (inclined bevels) and drilling a multitude of difficult shapes.

Job data and grinding condition settings are displayed in high-resolution graphics on the large, color LCD touch screen for easy job verification. Processing-command data can be entered using the iRx Editor tablet application. This application allows for real-time, interactive, remote support and combines useful functions such as sending/receiving of log files, software upgrades and more, for uninterrupted operation. Retouching after processing can be done automatically by entering the retouch information via the tablet.

The Xtrimer SE-1 is available as a stand-alone edger and is also engineered to operate in a small, medium or large volume capacity in conjunction with the company’s AES robotic units. 

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.